REQUEST A DEMO
Total
USD $0.00
« Back to previous page

Southeast Asia Pharma and Healthcare Sector Report 2019/2020

An EMIS Insights Industry Report
EMIS is an ISI Emerging Markets Group Company
Date: May 2019
Pages: 72
Available in: English

With 1.4bn population each as of 2017, India and China are the most numerous countries out of the six forming the focus of this report. However, the two countries differ widely in terms of per capita GDP, with that of China being more than twice that of India. In 2017, India reported a fertility rate of 2.1 against only 1.5 for China, suggesting that the Chinese population is ageing at a faster rate compared to that of India. Observed life expectancy for both sexes increased between 1990 and 2017 in both China and India, but as of 2017, China reported higher life expectancy for both men and women compared to India. Thus, China first of the two countries will have to deal with substantial masses of senior population who will pose specific demands on its healthcare policies and facilities, as well as on the range of drugs available in the country.  

 

This report provides a complete and detailed analysis of the healthcare and pharmaceutical sector for Southeast Asia . EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

  • Understand the key elements at play in the healthcare and pharmaceutical sector in Southeast Asia
  • Access forecasts for growth in the sector
  • View key data on healthcare spending and health insurance in Southeast Asia
  • Crystallise the forces both driving and restraining this sector in Southeast Asia
  • Build a complete perspective on sector trade, investment and employment
  • Understand the competitive landscape and who the major players are
  • View M&A activity and major deals
  • Gain an understanding of the regulatory environment for the sector in Southeast Asia
  • Build a clear picture of trends and issues for sub-sectors (medical institutions, pharmaceuticals manufacturing and distribution channels).

 

See below for a complete table of report contents:

Southeast Asia Pharma and Healthcare Sector Report 2019/2020 - Page 1
Buy full report USD 495.00 Payment methods include:

DOWNLOAD A SAMPLE
Have a question?

Email us at: customerenquiries@emis.com

SEE BELOW FOR A COMPLETE TABLE OF REPORT CONTENTS:

Southeast Asia Pharma and Healthcare Sector Report 2019/2020 -  Page 3
Southeast Asia Pharma and Healthcare Sector Report 2019/2020 -  Page 4
Southeast Asia Pharma and Healthcare Sector Report 2019/2020 -  Page 7
Southeast Asia Pharma and Healthcare Sector Report 2019/2020 -  Page 26
ONCE YOU HAVE COMPLETED YOUR PURCHASE,
YOU WILL BE ABLE TO DOWNLOAD THIS REPORT IMMEDIATELY AS A PDF
If you have any questions, please contact customerenquires@emis.com
Buy full report
Need ongoing access to company, industry or country information?